Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Mouse models expressing human ACE2 for coronavirus disease 2019 have been frequently used to understand its pathogenesis and develop therapeutic strategies against SARS-CoV-2. Given that human TMPRSS2 supports viral entry, replication, and pathogenesis, we established a double-transgenic mouse model expressing both human ACE2 and TMPRSS2 for SARS-CoV-2 infection. Co-overexpression of both genes increased viral infectivity in vitro and in vivo. Double-transgenic mice showed significant body weight loss, clinical disease symptoms, acute lung injury, lung inflammation, and lethality in response to viral infection, indicating that they were highly susceptible to SARS-CoV-2. Pretreatment with the TMPRSS2 inhibitor, nafamostat, effectively reduced virus-induced weight loss, viral replication, and mortality in the double-transgenic mice. Moreover, the susceptibility and differential pathogenesis of SARS-CoV-2 variants were demonstrated in this animal model. Together, our results demonstrate that double-transgenic mice could provide a highly susceptible mouse model for viral infection to understand SARS-CoV-2 pathogenesis and evaluate antiviral therapeutics against coronavirus disease 2019.
Abstract
Mouse models expressing human ACE2 for coronavirus disease 2019 have been frequently used to understand its pathogenesis and develop therapeutic strategies against SARS-CoV-2. Given that human TMPRSS2 supports viral entry, replication, and pathogenesis, we established a double-transgenic mouse model expressing both human ACE2 and TMPRSS2 for SARS-CoV-2 infection. Co-overexpression of both genes increased viral infectivity in vitro and in vivo. Double-transgenic mice showed significant body weight loss, clinical disease symptoms, acute lung injury, lung inflammation, and lethality in response to viral infection, indicating that they were highly susceptible to SARS-CoV-2. Pretreatment with the TMPRSS2 inhibitor, nafamostat, effectively reduced virus-induced weight loss, viral replication, and mortality in the double-transgenic mice. Moreover, the susceptibility and differential pathogenesis of SARS-CoV-2 variants were demonstrated in this animal model. Together, our results demonstrate that double-transgenic mice could provide a highly susceptible mouse model for viral infection to understand SARS-CoV-2 pathogenesis and evaluate antiviral therapeutics against coronavirus disease 2019.
참고문헌 (28)
- Munoz-Fontela, C., "Animal models for COVID-19", Nature, 586, pp.509~515 (2020)
- Chu, H., "Animal models in SARS-CoV-2 research", Nat. Methods, 19, pp.392~394 (2022)
- McCray, P. B. Jr, "Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus", J. Virol, 81, pp.813~821 (2007)
- Huang, Y., "Structural and functional prop erties of SARS-CoV-2 spike protein : potential antivirus drug development for COVID-19", Acta Pharm. Sin, 41, pp.1141~1149 (2020)
- Winkler, E. S., "SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function", Nat. Immunol, 21, pp.1327~1335 (2020)
- Ord, M., "The sequence at Spike S1", S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS CoV, 2020, pp.10, 16944~
- Crawford, K. H. D., "Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays", Viruses, 12, pp.513~ (2020)
- Nie, J., "Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay", Nat. Protoc, 15, pp.3699~3715 (2020)
- Jeong, Y. D., "Designing isolation guidelines for COVID-19 patients with rapid antigen tests", Nat. Commun, 13, pp.4910~ (2022)
- Matsuyama, S., "Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells", Proc. Natl Acad. Sci. USA, 117, pp.7001~7003 (2020)
- Hossain, M. G., "Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination", J. Med. Virol, 94, pp.1815~1820 (2022)
- Reed, L. J., "A simple method of estimating fifty per cent endpoints", Am. J. Epidemiol, 27, pp.493~497 (1938)
- Ramakrishnan, M. A., "Determination of 50% endpoint titer using a simple formula", World J. Virol, 5, pp.85~ (2016)
- Meng, B., "Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infec tivity and fusogenicity", Nature, 603, pp.706~714 (2022)
- Hoffmann, M., "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
- Johnson, B. A., "Loss of furin cleavage site attenuates SARS-CoV-2 patho genesis", Nature, 591, pp.293~299 (2021)
- Li, K., "Jr The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID 19", mBio, 12, pp.e0097021~ (2021)
- Tao, K., "The biological and clinical significance of emerging SARS-CoV-2variants", Nat. Rev. Genet, 22, pp.757~773 (2021)
- Parra-Lucares, A., "Emergence of SARS-CoV-2 variants in the world: how could this happen?", Life, 12, pp.194~ (2022)
- Natekar, J. P., "Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice", Viruses, 14, pp.1139~ (2022)
- Jia, H., "ACE2 mouse models : a toolbox for cardiovascular and pulmonary research", Nat. Commun, 11, pp.5165~ (2020)
- Bao, L., "The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice", Nature, 583, pp.830~833 (2020)
- Lee, S., "Immunological and pathological peculiarity of severe acute respiratory syndrome coronavirus 2 beta variant", Microbiol. Spectr, 10, pp.e0237122~ (2022)
- Peacock, T. P., "The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets", Nat. Microbiol, 6, pp.899~909 (2021)
- Koch, J., "TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells", EMBO J, 40, pp.e107821~ (2021)
- Sasaki, M., "SARS-CoV-2 variants with mutations at the S1", S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells, 2021, pp.17, e1009233~
- Iwata-Yoshikawa, N., "Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways", Nat. Commun, 13, pp.6100~ (2022)
- Chan, J. F., "Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2", Cell Rep. Med, 3, pp.100743~ (2022)